Drug intelligence / Profile preview

dimeric naphthoquinone 3

Development stage
Preclinical
Lead developer
Higher Education Commission of Pakistan
Modality
Small Molecules
Administration
Intranasal, Oral, Transdermal, Parenteral, Intravenous, Intramuscular
01

Overview

**Dimeric naphthoquinone 3** is a naturally occurring small molecule isolated from the roots of *Diospyros lotus*. It is a dimeric naphthoquinone, specifically characterized as 8,5′,8′-trihydroxy-6,6′-dimethyl-7,3′-binaphthyl-1,4,1′,4′-tetraone. This compound exhibits **antiproliferative and cytotoxic effects** on mouse T-cell lymphoma cell lines, both parental and multidrug-resistant (MDR) variants, with notable activity against P-glycoprotein (ABCB1)–mediated MDR. The mechanism of action includes reversal of MDR and induction of cytotoxicity, likely via modulation of *P*-glycoprotein and apoptosis induction. It is part of a class of naphthoquinone dimers actively researched for their anticancer potential, especially as MDR modulators[1][3][6].

Other names
8,5′,8′-trihydroxy-6,6′-dimethyl-7,3′-binaphthyl-1,4,1′,4′-tetraone
02

Targets

NQO1ABCB1 (P-glycoprotein)

Beyond the preview

Go deeper on dimeric naphthoquinone 3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dimeric naphthoquinone 3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call